Financials

  • Market Capitalization 150.35 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.67
Rapporto prezzo/fatturato
23.7

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3805
YDES
YD Bio Limited - Ordinary Shares
2.15 USD-3.59%-7.33%-34.05%-73.13%152.20 M USD
3807
HURA
TuHURA Biosciences, Inc. - Common Stock
2.38 USD-0.42%+1.28%+0.85%+1.28%151.56 M USD
3813
IFRX
InflaRx N.V. - Common Stock
2.06 USD+0.49%-3.29%+28.75%+136.78%148.92 M USD
3829
CNTB
Connect Biopharma Holdings Limited - American Depositary Shares
2.26 USD-9.96%-4.24%+2.26%+61.43%142.30 M USD

Notizie